Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| (NASDAQ: CNTX) | Delayed: 0.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $ | |||
| Open | $0.30 | 52 Week Low | $ | |||
| Day High | $0.31 | P/E | N/A | |||
| Day Low | $0.30 | EPS | $ | |||
| Volume | 588,668 | |||||
